{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T22:49:53Z","timestamp":1789512593344,"version":"build-2803163510"},"reference-count":68,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1002\/jps.22805","type":"journal-article","created":{"date-parts":[[2011,11,12]],"date-time":"2011-11-12T01:52:05Z","timestamp":1321062725000},"page":"664-680","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":144,"title":["Novel Furosemide Cocrystals and Selection of High Solubility Drug Forms"],"prefix":"10.1016","volume":"101","author":[{"given":"N. Rajesh","family":"Goud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swarupa","family":"Gangavaram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuthuru","family":"Suresh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharmistha","family":"Pal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sulur G.","family":"Manjunatha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudhir","family":"Nambiar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashwini","family":"Nangia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1002\/jps.22805_bb0010","article-title":"Developing solid oral dosage forms: Pharmaceutical theory and practice","year":"2009"},{"key":"10.1002\/jps.22805_bb0015","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1021\/cen-v088n022.p013","article-title":"Finding solutions","volume":"88","author":"Thayer","year":"2010","journal-title":"Chem Eng News"},{"key":"10.1002\/jps.22805_bb0020","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1023\/A:1016212804288","article-title":"Theoretical basis for a biopharmaceutical drug classification: correlation of in vitro drug product dissolution and in vivo bioavailability","volume":"12","author":"Amidon","year":"1995","journal-title":"Pharm Res"},{"key":"10.1002\/jps.22805_bb0025","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1208\/s12248-009-9144-x","article-title":"Prediction of solubility and permeability class membership: Provisional BCS classification of world's top oral drugs","volume":"11","author":"Dahan","year":"2009","journal-title":"AAPS J"},{"key":"10.1002\/jps.22805_bb0030","first-page":"239","article-title":"Modern pharmacology with clinical applications","author":"Friedman","year":"1997"},{"key":"10.1002\/jps.22805_bb0035","series-title":"Encyclopedia of heart diseases","first-page":"486","author":"Khan","year":"2006"},{"key":"10.1002\/jps.22805_bb0040","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.addr.2007.05.011","article-title":"Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates","volume":"59","author":"Blagden","year":"2007","journal-title":"Adv Drug Del Rev"},{"key":"10.1002\/jps.22805_bb0045","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.drudis.2008.03.004","article-title":"The role of cocrystals in pharmaceutical science","volume":"13","author":"Shan","year":"2008","journal-title":"Drug Discov Today"},{"key":"10.1002\/jps.22805_bb0050","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0378-5173(88)90225-6","article-title":"Furosemide crystal forms: Solid state and physicochemical analyses","volume":"47","author":"Doherty","year":"1988","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.22805_bb0055","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0378-5173(90)90185-7","article-title":"Physicochemical characterization of furosemide modifications","volume":"60","author":"Matsuda","year":"1990","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.22805_bb0060","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.5012\/bkcs.2009.30.10.2265","article-title":"Polymorphic forms of furosemide characterized by THz time domain spectroscopy","volume":"30","author":"Ge","year":"2009","journal-title":"Bull Korean Chem Soc"},{"key":"10.1002\/jps.22805_bb0065","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1107\/S0108768106016211","article-title":"Further errors in polymorph identification: Furosemide and finasteride","author":"Karami","year":"2006","journal-title":"Acta Crystallogr"},{"key":"10.1002\/jps.22805_bb0070","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1021\/cg100098z","article-title":"Conformational and synthon polymorphism in furosemide (Lasix)","volume":"10","author":"Babu","year":"2010","journal-title":"Cryst Growth Des"},{"key":"10.1002\/jps.22805_bb0075","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0168-3659(02)00322-X","article-title":"Nano encapsulation of furosemide microcrystals for controlled drug release","volume":"86","author":"Ai","year":"2003","journal-title":"J Control Release"},{"key":"10.1002\/jps.22805_bb0080","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/j.2042-7158.1992.tb05483.x","article-title":"Amorphism and Physicochemical stability of spray-dried frusemide","volume":"44","author":"Matsuda","year":"1992","journal-title":"J Pharm Pharmacol"},{"key":"10.1002\/jps.22805_bb0085","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0378-5173(98)00260-9","article-title":"Enhanced dissolution of furosemide by coprecipitating or cogrinding with crospovidone","volume":"175","author":"Shin","year":"1998","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.22805_bb0090","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0378-5173(02)00586-0","article-title":"Physicochemical characterization of solid dispersion of furosemide with TPGS","volume":"251","author":"Shin","year":"2003","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.22805_bb0095","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3109\/03639049809082348","article-title":"Improvement of dissolution properties of furosemide by complexation with \u03b2-cyclodextrin","volume":"24","author":"\u00d6zdemir","year":"1998","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1002\/jps.22805_bb0100","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1023\/A:1008032324924","article-title":"Freeze dried complexes of furosemide with \u03b2-cyclodextrin derivatives","volume":"34","author":"Kreaz","year":"1999","journal-title":"J Incl Phenom Macrocycl Chem"},{"key":"10.1002\/jps.22805_bb0105","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s10847-006-9056-7","article-title":"Investigation of drug nanoparticle formation by cogrinding with cyclodextrins: studies for Indomethacin, Furosemide and Naproxen","volume":"56","author":"Wongmekiat","year":"2006","journal-title":"J Incl Phenom Macrocycl Chem"},{"key":"10.1002\/jps.22805_bb0110","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1211\/0022357023439","article-title":"Aqueous solubilization of furosemide by supramolecular complexation with 4-sulphonic calix[n]arenes","volume":"56","author":"Yang","year":"2004","journal-title":"J Pharm Pharmacol"},{"key":"10.1002\/jps.22805_bb0115","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ijpharm.2009.12.055","article-title":"Microencapsulation of self-microemulsifying system: Improving solubility and permeability of furosemide","volume":"388","author":"Zvonar","year":"2010","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.22805_bb0120","first-page":"235","article-title":"Spontaneously self-assembled micelles from poly(ethylene glycol)-b-poly(\u03b5-caprolactone-co-trimethylene carbonate) for drug solubilization","volume":"63","author":"Latere Dwan'lsa","year":"2008","journal-title":"Pharmazie"},{"key":"10.1002\/jps.22805_bb0125","first-page":"37","article-title":"Newer approaches to self emulsifying drug delivery system","volume":"2","author":"Shaji","year":"2010","journal-title":"Int J Pharm Pharm Sci"},{"key":"10.1002\/jps.22805_bb0130","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/jps.2600820108","article-title":"Hygroscopic stability and dissolution properties of spray-dried solid dispersions of furosemide with eudragit","volume":"82","author":"Otsuka","year":"1993","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.22805_bb0135","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S1871-5125(10)35009-6","article-title":"Cocrystal systems of pharmaceutical interest: 2007-2008","volume":"35","author":"Brittain","year":"2010","journal-title":"Profiles Drug Substances, Excipients Related Methodology"},{"key":"10.1002\/jps.22805_bb0140","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/jps.20578","article-title":"Pharmaceutical Co-Crystals","volume":"95","author":"Vishweshwar","year":"2006","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.22805_bb0145","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1111\/j.2042-7158.2010.01133.x","article-title":"Benefits of cocrystallisation in pharmaceutical materials science: an update","volume":"62","author":"Fri\u0161\u010di\u0107","year":"2010","journal-title":"J Pharm Pharmacol"},{"key":"10.1002\/jps.22805_bb0150","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1002\/anie.199523111","article-title":"Supramolecular synthons in crystal engineering\u2013A new organic synthesis","volume":"34","author":"Desiraju","year":"1995","journal-title":"Angew Chem, Int Ed Engl"},{"key":"10.1002\/jps.22805_bb0155","doi-asserted-by":"crossref","first-page":"8342","DOI":"10.1002\/anie.200700534","article-title":"Crystal Engineering: A holistic view","volume":"46","author":"Desiraju","year":"2007","journal-title":"Angew Chem, Int Ed"},{"key":"10.1002\/jps.22805_bb0160","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1021\/cg034047i","article-title":"Cocrystals of 1,3,5-cyclohexanetricarboxylic acid with 4,4' bipyridine homologues: Acid\u2013pyridine hydrogen bonding in neutral and ionic complexes","volume":"3","author":"Bhogala","year":"2003","journal-title":"Cryst Growth Des"},{"key":"10.1002\/jps.22805_bb0165","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1021\/mp070003j","article-title":"Sulfa drugs as model cocrystal formers","volume":"4","author":"Caira","year":"2007","journal-title":"Mol Pharmaceutics"},{"key":"10.1002\/jps.22805_bb0170","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1107\/S0108768189006634","article-title":"Structural study of Histamine H2\u2013receptor antagonists. Five 3-[2-(diaminomethyleneamino)-4-thiazolylmethylthio] propionamidine and amide derivatives","author":"Ishida","year":"1989","journal-title":"Acta Crystallogr"},{"key":"10.1002\/jps.22805_bb0175","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1021\/cg200094x","article-title":"Sulfonamide\u2013pyridine-N-oxide cocrystals","volume":"11","author":"Goud","year":"2011","journal-title":"Cryst Growth Des"},{"key":"10.1002\/jps.22805_bb0180","series-title":"Furosemide salts","author":"Pellegata","year":"1990"},{"key":"10.1002\/jps.22805_bb0185","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0731-7085(00)00378-2","article-title":"Furosemide assay in pharmaceuticals by micellar liquid chromatography: Study of the stability of the drug","volume":"23","author":"Carda-Broch","year":"2000","journal-title":"J Pharm Biomed Anal"},{"key":"10.1002\/jps.22805_bb0190","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1021\/mp070001z","article-title":"An overview of Pharmaceutical cocrystals as Intellectual property","volume":"4","author":"Trask","year":"2007","journal-title":"Mol Pharmaceutics"},{"key":"10.1002\/jps.22805_bb0195","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1021\/cg200492w","article-title":"Solubility Advantage of Amorphous Drugs and Pharmaceutical Cocrystals","volume":"11","author":"Babu","year":"2011","journal-title":"Cryst Growth Des"},{"key":"10.1002\/jps.22805_bb0200","unstructured":"GRAS chemical list. Accessed atwww.fda.gov\/Food\/FoodIngredientsPackaging\/GenerallyRecognizedasSafeGRAS\/GRASSubstancesSCOGSDatabase\/default.htm."},{"key":"10.1002\/jps.22805_bb0205","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1021\/mp0601345","article-title":"The salt-cocrystal continuum: the influence of crystal structure on ionization state","volume":"4","author":"Childs","year":"2007","journal-title":"Mol Pharmaceutics"},{"key":"10.1002\/jps.22805_bb0210","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1021\/cg8007014","article-title":"Solid state NMR analysis of organic cocrystals and complexes","volume":"9","author":"Vogt","year":"2009","journal-title":"Cryst Growth Des"},{"key":"10.1002\/jps.22805_bb0215","doi-asserted-by":"crossref","first-page":"4453","DOI":"10.1002\/jps.22164","article-title":"Salt or co-crystal? Determination of protonation state by x-ray photoelectron spectroscopy (XPS)","volume":"99","author":"Stevens","year":"2010","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.22805_bb0220","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1039\/b207369m","article-title":"Mechanochemistry and co-crystal formation: Effect of solvent on reaction kinetics","volume":"20","author":"Shan","year":"2002","journal-title":"Chem Commun"},{"key":"10.1002\/jps.22805_bb0225","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1081\/DDC-100100271","article-title":"Structure-solubility relationship and thermal decomposition of furosemide","volume":"26","author":"Beyers","year":"2000","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1002\/jps.22805_bb0230","doi-asserted-by":"crossref","first-page":"8199","DOI":"10.1021\/ja0541332","article-title":"Solid-state acid-base interactions in complexes of heterocyclic bases with dicarboxylic acids: Crystallography, hydrogen bond analysis and 15N NMR spectroscopy","volume":"128","author":"Li","year":"2006","journal-title":"J Am Chem Soc"},{"key":"10.1002\/jps.22805_bb0235","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1002\/anie.199515551","article-title":"Patterns in hydrogen bonding: Functionality and graph set analysis in crystals","volume":"34","author":"Bernstein","year":"1995","journal-title":"Angew Chem, Int Ed Engl"},{"key":"10.1002\/jps.22805_bb0240","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.jpba.2010.12.020","article-title":"An overview of recent studies on the analysis of pharmaceutical polymorphs","volume":"55","author":"Chieng","year":"2011","journal-title":"J Pharm Biomed Anal"},{"key":"10.1002\/jps.22805_bb0245","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/b100995","article-title":"Crystal Engineering of organic cocrystals by the solid-state grinding approach","volume":"254","author":"Trask","year":"2005","journal-title":"Top Curr Chem"},{"key":"10.1002\/jps.22805_bb0250","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1021\/cg900129f","article-title":"Pharmaceutical cocrystals and their physicochemical properties","volume":"9","author":"Schultheiss","year":"2009","journal-title":"Cryst Growth Des"},{"key":"10.1002\/jps.22805_bb0255","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1039\/C0CC04117C","article-title":"New polymorphs of isonicotinamide and nicotinamide","volume":"47","author":"Li","year":"2011","journal-title":"Chem Commun"},{"key":"10.1002\/jps.22805_bb0260","doi-asserted-by":"crossref","first-page":"4188","DOI":"10.1039\/c1ce05160a","article-title":"The crystal structures and melting point properties of isonicotinamide cocrystals with alkanediacids HO2C(CH2)n\u20132CO2H, n = 7\u20139","volume":"13","author":"Thompson","year":"2011","journal-title":"CrystEngComm"},{"key":"10.1002\/jps.22805_bb0265","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1021\/cg034037h","article-title":"Molecular complexes of homologous alkanedicarboxylic acids with isonicotinamide: X-ray crystal structures, hydrogen bond synthons and melting point alternation","volume":"3","author":"Vishweshwar","year":"2003","journal-title":"Cryst Growth Des"},{"key":"10.1002\/jps.22805_bb0270","doi-asserted-by":"crossref","unstructured":"Cherukuvada S, Babu NJ, Nangia A. Nitrofurantoin-paminobenzoic acid cocrystal: Hydration stability and dissolution rate studies. J Pharm Sci 100:3233\u20133244.","DOI":"10.1002\/jps.22546"},{"key":"10.1002\/jps.22805_bb0275","doi-asserted-by":"crossref","first-page":"13335","DOI":"10.1021\/ja048114o","article-title":"Crystal engineering approach to forming cocrystals of amine hydrochlorides with organic acids. Molecular complexes of fluoxetine hydrochloride with benzoic, succinic and fumaric acids","volume":"126","author":"Childs","year":"2004","journal-title":"J Am Chem Soc"},{"key":"10.1002\/jps.22805_bb0280","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1517\/17425247.4.4.403","article-title":"Drug-delivery strategies for poorly water soluble drugs","volume":"4","author":"Fahr","year":"2007","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1002\/jps.22805_bb0285","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1021\/cg901010v","article-title":"Effects of crystal form on solubility and pharmacokinetics: a crystal engineering case study of lamotrigine","volume":"10","author":"Cheney","year":"2010","journal-title":"Cryst Growth Des"},{"key":"10.1002\/jps.22805_bb0290","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1021\/cg801039j","article-title":"Solubility advantage of pharmaceutical cocrystals","volume":"9","author":"Good","year":"2009","journal-title":"Cryst Growth Des"},{"key":"10.1002\/jps.22805_bb0295","doi-asserted-by":"crossref","first-page":"3976","DOI":"10.1021\/cg9001187","article-title":"Understanding and predicting the effect of cocrystal components and pH on cocrystal solubility","volume":"9","author":"Bethune","year":"2009","journal-title":"Cryst Growth Des"},{"key":"10.1002\/jps.22805_bb0300","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1021\/cg800632r","article-title":"Role of cocrystal and solution chemistry on the formation and stability of cocrystals with different stoichiometry","volume":"9","author":"Jayasankar","year":"2009","journal-title":"Cryst Growth Des"},{"key":"10.1002\/jps.22805_bb0305","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1021\/cg900885n","article-title":"Co-crystallization in the caffeine\/maleic acid system: Lessons from phase equilibria","volume":"10","author":"Guo","year":"2010","journal-title":"Cryst Growth Des"},{"key":"10.1002\/jps.22805_bb0310","unstructured":"Powder Cell, a program for structure visualization, powder pattern calculation and profile fitting. Accessed atwww.ccp14.ac.uk\/tutorial\/powdercell."},{"key":"10.1002\/jps.22805_bb0315","unstructured":"Cambridge Crystallographic Data Center, Cambridge Structural Database, version 5.32, November 2010, August 2011 update Available atwww.ccdc.cam.ac.uk\/products\/csd."},{"key":"10.1002\/jps.22805_bb0320","series-title":"SAINT-Plus, version 6.45","year":"2003"},{"key":"10.1002\/jps.22805_bb0325","series-title":"SADABS, program for empirical absorption correction of area detector data","author":"Sheldrick","year":"1997"},{"key":"10.1002\/jps.22805_bb0330","series-title":"SHELXS-97 and SHELXL-97","author":"Sheldrick","year":"1997"},{"key":"10.1002\/jps.22805_bb0335","series-title":"PLATON, a multipurpose crystallographic tool","author":"Spek","year":"2002"},{"key":"10.1002\/jps.22805_bb0340","series-title":"X-Seed, graphical interface to SHELX-97 and POV-Ray","author":"Barbour","year":"1999"},{"key":"10.1002\/jps.22805_bb0345","first-page":"117","article-title":"Phase-solubility techniques","volume":"4","author":"Higuchi","year":"1965","journal-title":"Adv Anal Chem Instrum"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354915317329?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354915317329?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T06:06:19Z","timestamp":1668578779000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354915317329"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":68,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S0022354915317329"],"URL":"https:\/\/doi.org\/10.1002\/jps.22805","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel Furosemide Cocrystals and Selection of High Solubility Drug Forms","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1002\/jps.22805","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Wiley Periodicals, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}